QUE Oncology

QUE Oncology Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $16M
Latest Deal Amount
  • Investors
  • 5

QUE Oncology General Information


Developer of novel therapies intended to address unmet medical needs in the treatment of cancer and its consequences. The company's compound Q-122 is being initially developed for the treatment of hot flashes in women with breast cancer who are receiving anti-estrogen therapy. Q-122 will also enable doctors to address hot flashes associated with prostate cancer treatments as well as the broader menopausal market.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • Atlanta, GA
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

QUE Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 05-Jun-2017 $16M 0000 0000 Completed Pre-Clinical Trials
1. Joint Venture 01-Jan-2013 Completed Product Development

QUE Oncology Cap Table

To view QUE Oncology‘s complete cap table, request access »
Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000

QUE Oncology Executive Team (3)

Name Title Board Seat Contact Info
Rob Crombie Ph.D Chief Executive Officer & Board Member

2 Former Executives

QUE Oncology Board Members (7)

To view QUE Oncology‘s full board member team, request access »
Name Representing Role Since
Chris Nave Ph.D Brandon Capital Partners Board Member 000 0000
Dean Moss Ph.D Uniquest Board Member 000 0000
Dennis Liotta Ph.D Centrosome Ventures Board Member 000 0000
Elizabeth Cermak QUE Oncology Board Member 000 0000
John Richard Ph.D Self Board Member 000 0000

QUE Oncology Investors (5)

To view QUE Oncology‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Brandon Capital Partners Venture Capital Minority 000 0000 000000 0
Centrosome Ventures Venture Capital Minority 000 0000 000000 0
Uniseed Venture Capital Minority 000 0000 000000 0
Emory University Department of Human Genetics Corporation Minority 000 0000 000000 0
Uniquest Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial